| Title |
Regular treatment with formoterol for chronic asthma: serious adverse events
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2012
|
| DOI | 10.1002/14651858.cd006923.pub3 |
| Pubmed ID | |
| Authors |
Christopher J Cates, Matthew J Cates |
| Abstract |
Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 50% |
| Members of the public | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 268 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | <1% |
| Germany | 1 | <1% |
| South Africa | 1 | <1% |
| United Kingdom | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 262 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 41 | 15% |
| Researcher | 29 | 11% |
| Student > Bachelor | 22 | 8% |
| Student > Ph. D. Student | 19 | 7% |
| Student > Postgraduate | 17 | 6% |
| Other | 53 | 20% |
| Unknown | 87 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 102 | 38% |
| Nursing and Health Professions | 22 | 8% |
| Social Sciences | 11 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 4% |
| Psychology | 9 | 3% |
| Other | 24 | 9% |
| Unknown | 89 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2019.
All research outputs
#5,189,339
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#7,107
of 11,499 outputs
Outputs of similar age
#32,698
of 174,458 outputs
Outputs of similar age from Cochrane database of systematic reviews
#103
of 177 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,458 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 177 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.